Thermo Fisher Scientific announce new China-based Customer Solution Center

Written by Alex Hyde, Future Science Group

International biotechnology product development company, Thermo Fisher Scientific (MA, USA), have announced the official opening of a new Pharma and BioPharma Customer Solution Center in Shanghai, China.

The Pharma and BioPharma Center will provide critical analytical process and specialized workflow expertise for Thermo Fisher Scientific customers based in China. The opening follows recent announcements of a Biosciences Customer Exploration Center in Shanghai (China) and also the expansion of the Thermo Fisher Scientific clinical trials logistics facility in Suzhou (Shanghai).

The Customer Solution Center aims to support the rapid delivery of novel and high-quality therapeutics throughout China. Zhong Feng, Director, Shangdong New Time Pharmaceutical (China) commented: “Thermo Fisher’s new Customer Solution Center in Shanghai is a hub of collaboration that will enable scientists across China to build new analytical workflows, enhance knowledge across our thriving pharmaceutical and biopharmaceutical sector, and help build capability and expertise in the region.”

Tony Acciartio, President of Thermo Fisher Scientific in China, explained: “The opening of a Pharma and BioPharma Customer Solution Center in China demonstrates our unwavering commitment to bringing best-in-class analytical technologies to laboratories across the region and supporting quality-by-design through scientific collaboration by scientists. The new Center reinforces our mission of enabling our customers to make the world healthier, cleaner and safer by helping laboratories in China nurture innovation and bring effective medicines to waiting patients.”


Keep up to date with the latest industry updates:

biomarkers-identificationAdvancing novel biomarker identification: Thermo Fisher Scientific collaborate with Owlstone Medical

mass spectrometer-watersFirst cyclic ion mobility mass spectrometer for commercial research installed at Aston University

bioagilytix-axquisitionBioAgilytix acquires Cambridge Biomedical